Home · Health · Nov 2 archive

FDA Approves Generic HIV Prevention Shot, Widening Access for Lower-Income Countries

Updated 6:18 PM ET · 5:23 PM ETConfirmedShare on

Health Desk

In Short: The FDA has approved a generic version of the HIV prevention drug lenacapavir, marking a significant step in expanding access to the medication in lower-income countries.

The FDA has approved a generic version of the HIV prevention drug lenacapavir, marking a significant step in expanding access to the medication in lower-income countries. CHAI CEO Dr Neil Buddy Shah praised the rapid approval, saying it should set a new standard for global health.

The agreement, signed in October 2024, limits the sale of the generics to 120 high-incidence, resource-limited countries. Reddy’s Laboratories, one of the world’s largest generic drugmakers, plans to start shipping the medicine next month.

Jessica Burry, a technical officer at Unitaid, noted that some countries might fast-track regulatory approvals based on a reliance mechanism on the US FDA. Dr Reddy's expects the broader rollout of the drug across eligible countries by 2027.

India's imports from EFTA countries last year were at $32.4 billion, with Switzerland accounting for a third of that number. Both the Section 301 investigation on New Delhi and the trade deal have resulted in a convergence between the countries.

The Media Line is on the ground in 12 Middle Eastern countries, reporting on tensions across the region. Iran’s central military command said it had received information that the United States, with the backing of some regional countries, was preparing to resume military actions against it.

The United States has warned of a rise in alleged Iranian efforts to target American diplomats and officials overseas, with some suspected assassination plots reportedly reaching advanced stages. US officials are also concerned that the Houthis could expand their campaign beyond Saudi Arabia to other countries in West Asia.

India's imports from EFTA countries last year were at $32.4 billion, with Switzerland accounting for a third of that number. If there are any gains, it may not be because of tariffs but because of perception building, since this is the first trade deal by India with any European country.

What this adds

Background

What's confirmed

• The FDA has approved a generic version of the HIV prevention drug lenacapavir, marking a significant step in expanding access to the medication in lower-income countries. CHAI CEO Dr Neil Buddy Shah praised the rapid approval, saying it should set a new standard for global health.
• The agreement, signed in October 2024, limits the sale of the generics to 120 high-incidence, resource-limited countries. Reddy’s Laboratories, one of the world’s largest generic drugmakers, plans to start shipping the medicine next month.
• Jessica Burry, a technical officer at Unitaid, noted that some countries might fast-track regulatory approvals based on a reliance mechanism on the US FDA. Dr Reddy's expects the broader rollout of the drug across eligible countries by 2027.
• India's imports from EFTA countries last year were at $32.4 billion, with Switzerland accounting for a third of that number. Both the Section 301 investigation on New Delhi and the trade deal have resulted in a convergence between the countries.
• The Media Line is on the ground in 12 Middle Eastern countries, reporting on tensions across the region. Iran’s central military command said it had received information that the United States, with the backing of some regional countries, was preparing to resume military actions against it.
• The United States has warned of a rise in alleged Iranian efforts to target American diplomats and officials overseas, with some suspected assassination plots reportedly reaching advanced stages. US officials are also concerned that the Houthis could expand their campaign beyond Saudi Arabia to other countries in West Asia.
• India's imports from EFTA countries last year were at $32.4 billion, with Switzerland accounting for a third of that number. If there are any gains, it may not be because of tariffs but because of perception building, since this is the first trade deal by India with any European country.

What's still developing

• German startup Isar Aerospace on Sunday said it would rapidly expand satellite deployments after the first orbital launch of its Spectrum rocket from Arctic Norway, a milestone for Europe’s efforts to secure independent access to space.
• Only the U.S. voted against it while six other countries — Serbia, Estonia, Georgia, Lithuania, Moldova and Ukraine — abstained.
• “Outside of that very narrow navigation application, there is no point in using it,” according to Mark Monmonier, a Syracuse University professor of geography. 24/7 coverage of breaking news and live events The United Nations General Assembly on Friday endorsed a new world map that represents Africa more accurately in its larger size, a culmination of a recent campaign led by African countries and advocacy groups.

Sources

• Health Policy Watchlink
• Medscapelink
• STATlink
• Bhaskarenglishlink
• AP Newslink
• Saudigazettelink
• The Indian Expresslink
• Cyprus-Maillink
• Themedialinelink
• Abcnewslink
• Timesofisraellink
• Kswolink
• AFPlink
• BBClink
• Newsweeklink
• WarpBeat — background on FDA Approves Generic HIV Prevention Shot, Widening Access for Lower-Income Countries link
• WPRI — video link